Clinical article
Clinical highlights: Alzheimer’s disease
The newsletter of this month is related to the relevance of eye tracking in Alzheimer’s disease
22 March 2023
Press release
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
19 December 2022
Clinical article
Clinical highlights: eye tracking and concussion
The newsletter of this month is related to the relevance of eye tracking in Concussion
31 October 2022
Clinical article
Clinical highlights: eye tracking in Deep Brain Stimulation
The newsletter of this month is related to the relevance of eye tracking in Deep Brain Stimulation (DBS) for Parkinson’s disease (PD).
29 September 2022
Clinical article
Clinical highlights: Eye movements in Multi System Atrophy
The newsletter of this month is related to the analysis of eye movements for differential diagnosis of Multiple System Atrophy.
19 July 2022
News
ISO 13485:2016 certification for design & development
P3Lab receives ISO 13485:2016 certification for design and development of eye tracking devices
9 June 2022
Clinical article
Eye movements in Parkinsonian syndromes
The newsletter of this month is related to the analysis of eye movements for the early diagnosis, differential diagnosis and follow-up of Parkinson’s disease.
1 June 2022
News
P3Lab raises 4.2 million euros
P3Lab, a European Medtech startup active in the early diagnosis of Parkinson Syndrome based on eye tracking, raises 4.2 million
6 November 2021
Clinical article
The beauty of studying eye movements
In today’s article, we shed light on the inspiration driving our mission, and share a few practical applications of eye tracking in the clinical practice. Hope you enjoy the read!
16 August 2021
